Skip to Content

UPSHER-SMITH 0226 20 mg (Morphine Sulfate Extended-Release 20 mg)

Pill with imprint UPSHER-SMITH 0226 20 mg is Yellow, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 20 mg. It is supplied by Upsher-Smith Laboratories, Inc..

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for UPSHER-SMITH 0226 20 mg

Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg
Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg Front
Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg Back
Morphine sulfate extended-release 20 mg UPSHER-SMITH 0226 20 mg

Morphine Sulfate Extended-Release

Imprint
UPSHER-SMITH 0226 20 mg
Strength
20 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Upsher-Smith Laboratories, Inc.
National Drug Code (NDC)
00832-0226

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.